Home » Venture Capital » All Companies

All Companies

Companysort icon Description Status Initial Date
<a href="/venture-capital/all-companies/receptos-inc">Receptos, Inc.</a> Developing therapeutic candidates for the treatment of immune and metabolic diseases. Public 2009 View Profile
<a href="/venture-capital/all-companies/quanterix-corporation">Quanterix Corporation</a> Developing ground-breaking tools in high definition diagnostics. Private 2007 View Profile
<a href="/venture-capital/all-companies/pronutria">Pronutria</a> Transforming global nutrition. Private 2010 View Profile
<a href="/venture-capital/all-companies/pervasis-therapeutics-inc">Pervasis Therapeutics, Inc.</a> Developing novel therapeutics to promote vascular repair. Private 2003 View Profile
<a href="/venture-capital/all-companies/perseptive-biosystems">PerSeptive BioSystems</a> Developer of high-technology purification, analysis and synthesis products Acquired 1991 View Profile
<a href="/venture-capital/all-companies/permeon-biologics-inc">Permeon Biologics Inc.</a> Pioneering a breakthrough class of intracellular biologics that target a broad spectrum of previously undruggable targets. Private 2011 View Profile
<a href="/venture-capital/all-companies/ontogeny-inc">Ontogeny, Inc.</a> Developmental biology insights for regenerative medicine therapies Acquired 1994 View Profile
<a href="/venture-capital/all-companies/oasys-water-inc">Oasys Water, Inc.</a> Leading the world in the development of forward osmosis based solutions for the treatment and desalination of high saline source waters. Private 2009 View Profile
<a href="/venture-capital/all-companies/novomer-inc">Novomer, Inc.</a> Commercializing a family of low-cost, high-performance, sustainable polymers and other chemicals. Private 2007 View Profile
<a href="/venture-capital/all-companies/morphotek-inc">Morphotek, Inc.</a> Genetically diverse organisms for agricultural, life science, and pharmaceutical use Acquired 2001 View Profile
<a href="/venture-capital/all-companies/moderna">moderna</a> Pioneering an entirely new drug modality using messenger RNA therapeutics™. Private 2010 View Profile
<a href="/venture-capital/all-companies/midori-renewables-inc">Midori Renewables Inc.</a> Commercializing chemical catalysts for upgrading waste biomass to fuels, chemicals, and materials. Private 2010 View Profile
<a href="/venture-capital/all-companies/medidametrics-inc">MedidaMETRICS, Inc.</a> Developing activity-based costing systems for healthcare providers. Private 2010 View Profile
<a href="/venture-capital/all-companies/mascoma-corporation">Mascoma Corporation</a> Developing innovative technology for the low-cost conversion of abundant biomass. Private 2006 View Profile
<a href="/venture-capital/all-companies/ls9-inc">LS9, Inc.</a> Technology leader in the commercial development of a growing portfolio of sustainable products to meet the needs of chemical and fuel markets worldwide. Private 2005 View Profile
<a href="/venture-capital/all-companies/joule-unlimited-inc">Joule Unlimited, Inc.</a> Capitalizing on the global abundance of waste CO2 to economically produce renewable fuels and chemicals. Private 2007 View Profile
<a href="/venture-capital/all-companies/intio">INTIO</a> Developing a software platform to support the emerging interventional oncology market. Private 2005 View Profile
<a href="/venture-capital/all-companies/interactive-supercomputing-corporation">Interactive Supercomputing Corporation</a> Software to enable applications transparent use of cluster supercomputers Acquired 2005 View Profile
<a href="/venture-capital/all-companies/intellivid">IntelliVid</a> Machine intelligence for video security Acquired 2002 View Profile
<a href="/venture-capital/all-companies/insmed-incorporated">INSMED, Incorporated</a> Pharmaceuticals for treatment of metabolic diseases and endocrine disorders Public 1996 View Profile